GSK plc (GSK) Nuvalent, Inc. - M&A Call - Slideshow
Developing story — details emerging. Check the source link for the latest updates.
??????? #nuvalent
2 headlines
Nuvalent shares surge 39% after UK's GSK agrees to buy the cancer drugmaker for $10.6 billion
The deal comes at a time of biotech dealmaking frenzy, driven by looming patent cliffs, newly buoyant public markets and drugmakers' race to bolster pipelines.